IncidentIQ-Logo-Blue-Horizontal (1).png
Incident IQ Partners with Level Access to Enhance Digital Accessibility
May 30, 2024 07:02 ET | Incident IQ
Atlanta, GA, May 30, 2024 (GLOBE NEWSWIRE) -- Incident IQ, a leader in workflow management solutions for K-12 school districts, has partnered with Level Access, the leading digital accessibility...
Elevar Logo for Common Use.png
Elevar Therapeutics Reports Landmark Median Overall Survival of 23.8 Months in First-Line Treatment for Unresectable Hepatocellular Carcinoma
May 30, 2024 07:00 ET | Elevar Therapeutics
Phase 3 CARES-310 study found combination of camrelizumab and rivoceranib continued to show sustained long-term survival compared with sorafenib as a first-line treatment for uHCCFinal analysis...
Omega_logo1.png
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
May 30, 2024 07:00 ET | Omega Therapeutics
CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable...
Grigeo Group_RGB.png
Notification on transactions concluded by a person associated to a management body of Grigeo Group AB
May 30, 2024 07:00 ET | Grigeo Group AB
Grigeo Group AB has received notifications on transactions in issuer's securities concluded by a legal entity associated to a management body of Grigeo Group AB (see attachments). Tomas...
TroilusLogo2.jpg
Troilus Discovers New At-Surface Gold Zone ‘West Rim’ With Intercept of 1.37 g/t AuEq Over 11m Within 200m of Reserve Pit and Confirms Continuity of Zone X22 Mineralization to Depth of 550m
May 30, 2024 07:00 ET | Troilus Gold Corp.
MONTREAL, Quebec, May 30, 2024 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to announce the discovery of a new gold zone named...
final_biomx_logo-01 (2).png
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024
May 30, 2024 07:00 ET | BiomX
GAITHERSBURG, Md. and NESS ZIONA, Israel, May 30, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and...
lantronix_logo_with-r-ball.png
Lantronix to Showcase AI-Driven Out-Of-Band Management Solutions at Cisco Live
May 30, 2024 07:00 ET | Lantronix, Inc.
Lantronix to Showcase AI-Driven Out-Of-Band Management Solutions at Cisco Live
PMV Logo New.png
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June
May 30, 2024 07:00 ET | PMV Pharmaceuticals, Inc.
PRINCETON, N.J., May 30, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
202306_Press Release-Amplify.png
Amplify ETFs Declares May Income Distributions for its ETFs
May 30, 2024 07:00 ET | Amplify ETFs
Amplify ETFs announces May income distributions for its ETFs.
SERB Pharmaceuticals
SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company’s growth
May 30, 2024 07:00 ET | BTG Specialty Pharmaceuticals
Philadelphia, PA, May 30, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, has appointed Vanessa Wolfeler as its new Chief Executive Officer (CEO) effective...